Bcal Diagnostics Ltd has released a press release.
Suspension from Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Response to ASX Price Query
- Trading Halt
- Pause in Trading
- Appointment of Strategic CEO to Lead Commercial Launch
- Share Purchase Plan Offer Booklet
Later from BCAL Diagnostics
- Reinstatement to Quotation
- BCAL Receives Firm Commitments to Raise $10.5 Million
- BCAL Commences US Operations
- Appendix 4E and Annual Report to Shareholders
- BCAL Diagnostics Receives NATA Accreditation
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics